LEADER 01517nam  2200433   450 
001 9910707234303321
005 20160623100343.0
035   $a(CKB)5470000002463167
035   $a(OCoLC)952096657
035   $a(OCoLC)995470000002463167
035   $a(EXLCZ)995470000002463167
100   $a20160623d2009      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 10$aAberrant claim patterns for inhalation drugs in South Florida
210  1$a[Washington, D.C.] :$cDepartment of Health and Human Services, Office of Inspector General,$d2009.
215   $a1 online resource (v, 26 pages) $cillustrations
300   $aTitle from title screen (viewed June 16, 2016).
300   $a"April 2009."
300   $a"OEI-03-08-00290."
320   $aIncludes bibliographical references.
517 1 $aAberrant claim patterns for inhalation drugs in South Florida
606   $aMedicare
606   $aIntranasal medication$zFlorida$xCosts$xAuditing
606   $aRespiratory therapy$zFlorida$xCosts$xAuditing
606   $aDrugs$xPrices$zFlorida$xAuditing
615  0$aMedicare.
615  0$aIntranasal medication$xCosts$xAuditing.
615  0$aRespiratory therapy$xCosts$xAuditing.
615  0$aDrugs$xPrices$xAuditing.
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910707234303321
996   $aAberrant claim patterns for inhalation drugs in South Florida$93310660
997   $aUNINA